Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors
Technology
E-040-2019
Patent ID
E-040-2019-0-US-07
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2022-0064324-A1
Application Number
17/421,334
IC
NCI
Date Filed
Date Issued
Patent PDF